468 related articles for article (PubMed ID: 27108294)
1. Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children.
Basu B; Babu BG; Mahapatra TK
Clin Exp Nephrol; 2017 Feb; 21(1):143-151. PubMed ID: 27108294
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
Wang J; Mao J; Chen J; Fu H; Shen H; Zhu X; Liu A; Shu Q; Du L
Nephrology (Carlton); 2016 Jan; 21(1):21-7. PubMed ID: 26697959
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
Bagga A; Hari P; Moudgil A; Jordan SC
Am J Kidney Dis; 2003 Dec; 42(6):1114-20. PubMed ID: 14655181
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
Sinha A; Gupta A; Kalaivani M; Hari P; Dinda AK; Bagga A
Kidney Int; 2017 Jul; 92(1):248-257. PubMed ID: 28318625
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of mycophenolate mofetil versus levamisole therapy in frequently relapsing and steroid dependent childhood nephrotic syndrome - A retrospective comparative analysis.
Sharma S; Kalra S; Shukla S; Sharma P
Nephrology (Carlton); 2022 Sep; 27(9):758-762. PubMed ID: 35619554
[TBL] [Abstract][Full Text] [Related]
6. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
Larkins NG; Liu ID; Willis NS; Craig JC; Hodson EM
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002290. PubMed ID: 32297308
[TBL] [Abstract][Full Text] [Related]
7. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
Horinouchi T; Sako M; Nakanishi K; Ishikura K; Ito S; Nakamura H; Oba MS; Nozu K; Iijima K
BMC Nephrol; 2018 Nov; 19(1):302. PubMed ID: 30382824
[TBL] [Abstract][Full Text] [Related]
8. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.
Webb NJ; Woolley RL; Lambe T; Frew E; Brettell EA; Barsoum EN; Trompeter RS; Cummins C; Wheatley K; Ives NJ
Health Technol Assess; 2019 May; 23(26):1-108. PubMed ID: 31156083
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Sinha A; Puraswani M; Kalaivani M; Goyal P; Hari P; Bagga A
Kidney Int; 2019 Jan; 95(1):210-218. PubMed ID: 30497684
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil for sustained remission in nephrotic syndrome.
Querfeld U; Weber LT
Pediatr Nephrol; 2018 Dec; 33(12):2253-2265. PubMed ID: 29750317
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic Syndrome.
Iijima K; Sako M; Oba M; Tanaka S; Hamada R; Sakai T; Ohwada Y; Ninchoji T; Yamamura T; Machida H; Shima Y; Tanaka R; Kaito H; Araki Y; Morohashi T; Kumagai N; Gotoh Y; Ikezumi Y; Kubota T; Kamei K; Fujita N; Ohtsuka Y; Okamoto T; Yamada T; Tanaka E; Shimizu M; Horinochi T; Konishi A; Omori T; Nakanishi K; Ishikura K; Ito S; Nakamura H; Nozu K;
J Am Soc Nephrol; 2022 Feb; 33(2):401-419. PubMed ID: 34880074
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Yadav M; Sinha A; Khandelwal P; Hari P; Bagga A
Pediatr Nephrol; 2019 May; 34(5):829-835. PubMed ID: 30194663
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil therapy for children with intractable nephrotic syndrome.
Okada M; Sugimoto K; Yagi K; Yanagida H; Tabata N; Takemura T
Pediatr Int; 2007 Dec; 49(6):933-7. PubMed ID: 18045300
[TBL] [Abstract][Full Text] [Related]
14. Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.
Fujinaga S; Hirano D; Mizutani A; Sakuraya K; Yamada A; Sakurai S; Shimizu T
Clin Exp Nephrol; 2017 Aug; 21(4):671-676. PubMed ID: 27558467
[TBL] [Abstract][Full Text] [Related]
15. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
Wu B; Mao J; Shen H; Fu H; Wang J; Liu A; Gu W; Shu Q; Du L
Nephrology (Carlton); 2015 Jan; 20(1):18-24. PubMed ID: 25312783
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil in children with frequently relapsing nephrotic syndrome: a report from the Southwest Pediatric Nephrology Study Group.
Hogg RJ; Fitzgibbons L; Bruick J; Bunke M; Ault B; Baqi N; Trachtman H; Swinford R
Clin J Am Soc Nephrol; 2006 Nov; 1(6):1173-8. PubMed ID: 17699344
[TBL] [Abstract][Full Text] [Related]
17. Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome.
Barletta GM; Smoyer WE; Bunchman TE; Flynn JT; Kershaw DB
Pediatr Nephrol; 2003 Aug; 18(8):833-7. PubMed ID: 12774223
[TBL] [Abstract][Full Text] [Related]
18. Levamisole in Frequently-relapsing and Steroid-dependent Nephrotic Syndrome.
Kiruba Samuel EM; Krishnamurthy S; Bhanudeep S; Muske S
Indian Pediatr; 2017 Oct; 54(10):831-834. PubMed ID: 28699616
[TBL] [Abstract][Full Text] [Related]
19. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.
Larkins N; Kim S; Craig J; Hodson E
Arch Dis Child; 2016 Apr; 101(4):404-8. PubMed ID: 26289063
[TBL] [Abstract][Full Text] [Related]
20. [Mycophenolate mofetil (MMF) as the first choice immunosuppressive drug in treatment of steroid-dependent nephrotic syndrome in children].
Ogarek I; Szczęsny-Choruz E; Wierzchowska-Słowiaczek E; Kwinta-Rybicka J; Stec Z; Moczulska A; Wilkosz K; Drożdż D
Pol Merkur Lekarski; 2018 Apr; 44(262):192-195. PubMed ID: 29775447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]